Collegium Raises $50 Million Financing to Support Commercial Development of its Lead Abuse-Deterrent Product Candidate. by longitudeadmin | Mar 10, 2015 | Portfolio News
Corcept Recorded Net Revenue of 9.0 Million in the Fourth Quarter of 2014, Compared to $4.1 Million for the Same Period in 2013. The Company Estimates 2015 Net Revenue Will Be Between $47 Million and $53 Million. by longitudeadmin | Mar 4, 2015 | Portfolio News
Collegium Pharmaceutical Announces Notice of Allowance for U.S. Patent Covering DETERx, and Abuse-Deterrent Analgesic for Chronic Pain by longitudeadmin | Feb 26, 2015 | Portfolio News
CoverMyMeds and Practice Fusion Partner to Bring Electronic Prior Authorizations for Medications to Over 110,000 of Practice Fusion’s Users by longitudeadmin | Feb 17, 2015 | Portfolio News
